Humana's Trading Volume Drops 48.8% to $480 Million, Ranked 222nd Amid Medicare Advantage Turmoil

On July 21, 2025, Humana's trading volume reached $480 million, a significant 48.8% decrease from the previous day, placing it at the 222nd position in the day's stock market rankings. Humana's stock price increased by 1.37%.

Humana faced a setback when a federal judge dismissed its lawsuit aimed at reinstating higher quality ratings for its 2025 Medicare Advantage plans. The ruling came after Humana argued that the Department of Health and Human Services acted arbitrarily in downgrading its ratings, which impact bonus payments and overall revenue. The judge ruled that Humana had not completed the necessary administrative process through the Department of Health and Human Services.

Despite the growth in Medicare Advantage enrollment, which now represents over half of all Medicare enrollment and is projected to reach 64% by 2034, the market has seen instability. Several Medicare Advantage payers reported unfavorable financial results in 2023, citing higher-than-expected care utilization as a key factor. This trend has led to increased cost-containment pressures and program changes, contributing to a volatile market in 2024.

A recent study by Trilliant Health revealed that home health utilization among Medicare Advantage beneficiaries has decreased significantly over the past few years. For certain demographics, home health utilization dipped as much as 63.1% over a five-year period. Humana, one of the largest insurers in the country with nearly six million Medicare Advantage members, had the highest home health utilization in 2023. The study emphasized the need for policymakers to balance cost containment with ensuring access to high-quality care, especially as projected spending growth outpaces that of Traditional Medicare.